Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 31 results.
User Information
Export Records
  1. 1.   Activity and structure of human (d)CTP deaminase CDADC1
  2. Slyvka, Anton; Rathore, Ishan; Yang, Renbin; Gewartowska, Olga; Kanai, Tapan; Lountos,George; Skowronek, Krzysztof; Czarnocki-Cieciura, Mariusz; Wlodawer,Alexander; Bochtler, Matthias
  3. Proceedings of the National Academy of Sciences of the United States of America. 2025, May 13; 122(19): e2424245122.
  1. 2.   Interactions of APOBEC3s with DNA and RNA
  2. Maiti, Atanu; Hou, Shurong; Schiffer, Celia A.; Matsuo,Hiroshi
  3. Current opinion in structural biology. 2021, Apr; 67: 195-204.
  1. 3.   Biochemical and biological studies of mouse APOBEC3
  2. Nair, S.; Sanchez-Martinez, S.; Ji, X.; Rein, A.
  3. Journal of Virology. 2014, Apr; 88(7): 3850-60.
  1. 4.   The Role of Amino-Terminal Sequences in Cellular Localization and Antiviral Activity of APOBEC3B
  2. Pak, V.; Heidecker, G.; Pathak, V. K.; Derse, D.
  3. Journal of Virology. 2011, Sep; 85(17): 8538-8547.
  1. 5.   Identification of Specific Determinants of Human APOBEC3F, APOBEC3C, and APOBEC3DE and African Green Monkey APOBEC3F That Interact with HIV-1 Vif
  2. Smith, J. L.; Pathak, V. K.
  3. Journal of Virology. 2010, Dec; 84(24): 12599-12608.
  1. 6.   Vif of Feline Immunodeficiency Virus from Domestic Cats Protects against APOBEC3 Restriction Factors from Many Felids
  2. Zielonka, J.; Marino, D.; Hofmann, H.; Yuhki, N.; Lochelt, M.; Munk, C.
  3. Journal of Virology. 2010, Jul; 84(14): 7312-7324.
  1. 7.   Inhibition of Xenotropic Murine Leukemia Virus-Related Virus by APOBEC3 Proteins and Antiviral Drugs
  2. Paprotka, T.; Venkatachari, N. J.; Chaipan, C.; Burdick, R.; Delviks-Frankenberry, K. A.; Hu, W. S.; Pathak, V. K.
  3. Journal of Virology. 2010, Jun; 84(11): 5719-5729.
  1. 8.   Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development
  2. Smith, J. L.; Bu, W.; Burdick, R. C.; Pathak, V. K.
  3. Trends in Pharmacological Sciences. 2009, Dec; 30(12): 638-646.
  1. 9.   Synthesis and conformational analysis of locked carbocyclic analogues of 1,3-diazepinone riboside, a high-affinity cytidine deaminase inhibitor
  2. Ludek, O. R.; Schroeder, G. K.; Liao, C.; Russ, P. L.; Wolfenden, R.; Marquez, V. E.
  3. Journal of Organic Chemistry. 2009, Aug 21; 74(16): 6212-23.
  1. 10.   Contrasting behavior of conformationally locked carbocyclic nucleosides of adenosine and cytidine as substrates for deaminases
  2. Marquez, V. E.; Schroeder, G. K.; Ludek, O. R.; Siddiqui, M. A.; Ezzitouni, A.; Wolfenden, R.
  3. Nucleosides, nucleotides & nucleic acids. 2009, May; 28(5): 614-32.
  1. 11.   Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA
  2. Friew, Y. N.; Boyko, V.; Hu, W. S.; Pathak, V. K.
  3. Retrovirology. 2009 6 AR 56
  1. 12.   Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance
  2. Jern, P.; Russell, R. A.; Pathak, V. K.; Coffin, J. M.
  3. Plos Pathogens. 2009 5(4):
  1. 13.   Guidelines for Naming Nonprimate APOBEC3 Genes and Proteins
  2. Larue, R. S.; Andresdottir, V.; Blanchard, Y.; Conticello, S. G.; Derse, D.; Emerman, M.; Greene, W. C.; Jonsson, S. R.; Landau, N. R.; Lochelt, M.; Malik, H. S.; Malim, M. H.; Munk, C.; O'Brien, S. J.; Pathak, V. K.; Strebel, K.; Wain-Hobson, S.
  3. Journal of Virology. 2009 83(2): 494-497.
  1. 14.   Species-specific Inhibition of APOBEC3C by the Prototype Foamy Virus Protein Bet
  2. Perkovic, M.; Schmidt, S.; Marino, D.; Russell, R. A.; Stauch, B.; Hofmann, H.; Kopietz, F.; Kloke, B. P.; Zielonka, J.; Strover, H.; Hermle, J.; Lindemann, D.; Pathak, V. K.; Schneider, G.; Lochelt, M.; Cichutek, K.; Munk, C.
  3. Journal of Biological Chemistry. 2009 284(9): 5819-5826.
  1. 15.   Dissecting APOBEC3G Substrate Specificity by Nucleoside Analog Interference
  2. Rausch, J. W.; Chelico, L.; Goodman, M. F.; Le Grice, S.
  3. Journal of Biological Chemistry. 2009 284(11): 7047-7058.
  1. 16.   Distinct Domains within APOBEC3G and APOBEC3F Interact with Separate Regions of Human Immunodeficiency Virus Type 1 Vif
  2. Russell, R. A.; Smith, J.; Barr, R.; Bhattacharyya, D.; Pathak, V. K.
  3. Journal of Virology. 2009 83(4): 1992-2003.
  1. 17.   Synthesis of conformationally locked carbocyclic 1,3-diazepinone nucleosides as inhibitors of cytidine deaminase
  2. Ludek, O. R.; Schroeder, G. K.; Wolfenden, R.; Marquez, V. E.
  3. Nucleic acids symposium series (2004). 2008 (52): 659-60.
  1. 18.   AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development
  2. Takizawa, M.; Tolarova, H.; Li, Z.; Dubois, W.; Lim, S.; Callen, E.; Franco, S.; Mosaico, M.; Feigenbaum, L.; Alt, F. W.; Nussenzweig, A.; Potter, M.; Casellas, R.
  3. Journal of Experimental Medicine. 2008 205(9): 1949-1957.
  1. 19.   Activation of p16 Gene Silenced by DNA Methylation in Cancer Cells by Phosphoramidate Derivatives of 2 '-Deoxyzebularine
  2. Yoo, C. B.; Valente, R.; Congiatu, C.; Gavazza, F.; Angel, A.; Siddiqui, M. A.; Jones, P. A.; McGuigan, C.; Marquez, V. E.
  3. Journal of Medicinal Chemistry. 2008 51(23): 7593-7601.
  1. 20.   Regulation of AID expression in the immune response
  2. Crouch, E. E.; Li, Z. Y.; Takizawa, M.; Fichtner-Feigl, S.; Gourzi, P.; Montano, C.; Feigenbaum, L.; Wilson, P.; Janz, S.; Papavasiliou, F. N.; Casellas, R.
  3. Journal of Experimental Medicine. 2007, May; 204(5): 1145-1156.
  1. 21.   Activation-induced deaminase cloning, localization, and protein extraction from young V-H-Mutant rabbit appendix
  2. Yang, G. B.; Obiakor, H.; Sinha, R. K.; Newman, B. A.; Hood, B. L.; Conrads, T. P.; Veenstra, T. D.; Mage, R. G.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, NOV 22; 102(47): 17083-17088.
  1. 22.   Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells
  2. Ben-Kasus, T.; Ben-Zvi, Z.; Marquez, V. E.; Kelley, J. A.; Agbaria, R.
  3. Biochemical Pharmacology. 2005, JUL 1; 70(1): 121-133.
  1. 23.   Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia
  2. Lemaire, M.; Momparler, L. F.; Bernstein, M. L.; Marquez, V. E.; Momparler, R. L.
  3. Anti-Cancer Drugs. 2005, MAR; 16(3): 301-308.
  1. 24.   Zebularine: A unique molecule for an epigenetically based strategy in cancer chemotherapy. The magic of its chemistry and biology
  2. Marquez, V. E.; Barchi, J. J.; Kelley, J. A.; Rao, K. V. R.; Agbaria, R.; Ben-Kasus, T.; Cheng, J. C.; Yoo, C. B.; Jones, P. A.
  3. Nucleosides Nucleotides & Nucleic Acids. 2005 24(5-7, Sp. Iss.): 305-318.
  1. 25.   Zebularine: A unique molecule for an epigenetically based strategy in cancer chemotherapy
  2. Marquez, V. E.; Kelley, J. A.; Agbaria, R.; Ben-Kasus, T.; Cheng, J. C.; Yoo, C. B.; Jones, P. A.
  3. Therapeutic Oligonucleotides: Transcriptional and Translational Strategies for Silencing Gene Expression. 2005; 1058 : 246-254.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel